Patent: 10,105,552
✉ Email this page to a colleague
Summary for Patent: 10,105,552
Title: | Formulations of histone deacetylase inhibitor and uses thereof |
Abstract: | Dosing regimens, methods of treatment, controlled release formulations, and combination therapies that include an HDAC inhibitor, or a pharmaceutically acceptable salt thereof, are described. |
Inventor(s): | Loury; David J. (Incline Village, NV), Buggy; Joseph J. (Mountain View, CA), Mody; Tarak D. (Sunnyvale, CA), Verner; Erik J. (San Mateo, CA), Purro; Norbert (Los Gatos, CA), Balasubramanian; Sriram (North Wales, PA) |
Assignee: | Pharmacyclics LLC (Sunnyvale, CA) |
Application Number: | 15/386,834 |
Patent Claims: | see list of patent claims |
Details for Patent 10,105,552
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2029-04-17 |
Genentech, Inc. | RITUXAN HYCELA | rituximab and hyaluronidase human | Injection | 761064 | 06/22/2017 | ⤷ Try a Trial | 2029-04-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |